Ruhr–UK Innovation Summit Matchmaking

16 – 24 Nov 2026 | Germany

Register
Register
Register

ImmunoSig Ltd

Company

www.immunosig.comManchester, United Kingdom
3 profile visits

About

ImmunoSig Ltd is a UK-based biotechnology company specialising in antibody profiling, immunoproteomics and biomarker discovery.

We provide specialist contract research services to biotechnology companies, pharmaceutical organisations and academic research groups, combining advanced experimental technologies with computational biology, biostatistics and machine learning.

Our core capabilities include:

  • Protein microarrays: High-content antibody profiling using platforms such as HuProt, covering more than 21,000 human proteins.

  • Peptide microarrays: Detailed characterisation of antibody responses, antigen recognition and epitope-specific reactivity.

  • Bioinformatics and data analysis: Statistical analysis, machine learning, biomarker identification and interpretation of complex immunological datasets.

  • Research study design: Support with experimental design, assay selection, data analysis strategies and interpretation of results.

Our expertise supports research across oncology, infectious diseases, vaccine development, immunology and translational medicine.

Research and diagnostic development

Alongside our commercial services, ImmunoSig is developing collaborative research programmes investigating antibody signatures as potential biomarkers for disease detection and monitoring.

One area of particular interest is discovering immune signatures associated with early-stage cancers, with the long-term aim of supporting the development of clinically useful diagnostic approaches.

International collaboration opportunities

We are interested in establishing partnerships with German and European biotechnology companies, pharmaceutical organisations, universities, hospitals and diagnostic developers.

We welcome discussions about:

  • Contract research and outsourced antibody profiling services.

  • Joint biomarker discovery and validation studies.

  • Access to well-characterised clinical sample cohorts.

  • Collaborative research and technology development.

  • UK–European research and innovation funding opportunities.

Our objective is to combine specialist immunological profiling with robust computational analysis to generate meaningful biological insights and support the development of future diagnostic technologies.

Social media

Areas of activity

Health

DiagnosticsClinical Research / Medical ResearchBiology / BiotechnologyOther Health

Representatives

Co-Founder and Director

ImmunoSig Ltd